Cellcept Tablet
Roll over image to zoom in
Cellcept in combination with corticosteroids and either ciclosporin or tacrolimus is indicated for-
- Prophylaxis of acute organ rejection and treatment of first or refractory organ rejection in patients receiving allogeneic renal transplants.
- Prophylaxis of acute organ rejection in patients receiving allogeneic cardiac transplants.
- Prophylaxis of acute organ rejection in patients receiving allogeneic hepatic transplants.
- Cellcept is indicated for induction and maintenance therapy of patients with Class III-V lupus nephritis (diagnosed according to International Society of Nephrology/Renal Pathology Society classification.
Cellcept is an immunosuppressive agent. It is an uncompetitive and reversible inhibitor of inosine monophosphate dehydrogenase (IMPDH). Therefore, it inhibits the de novo pathway of guanosine nucleotide synthesis without incorporation to DNA. Mycophenolic acid has cytostatic effects on lymphocytes. It has been shown to prevent the occurrence of acute rejection of kidney and heart allotransplantation. It also decreases antibody production.
Additional information
| Unit Price | 96 tk |
|---|---|
| Strip Price | 960 tk |
Reviews
There are no reviews yet.